Over the last 6 years, insiders at Guardant Health Inc have traded over 2,653,630,540$ worth of Guardant Health Inc stock and bought 2,438,210 units worth 45,173,576$ . The most active insiders traders include Bluebird (Cayman) Ltd Softb...、Bluebird (Cayman) Ltd Svf E...、Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of 2,415,822$. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth 162,774$.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: